Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457938 · ClinicalTrials.gov registry record · NA
Novel Therapies for Metabolic Complications of Lipodystrophies
A NA study of Diabetes and Insulin Resistance, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT00457938: Completed NA study of Diabetes and Insulin Resistance, sponsored by University of Texas Southwestern Medical Center.
NCT00457938 is a NA study of Diabetes and Insulin Resistance that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 4 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00457938, a NA study of Diabetes and Insulin Resistance, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
Lipodystrophies represent a therapeutic challenge with regards to the management of the diabetes, insulin resistance, hypertriglyceridemia and fatty liver which frequently present in conjunction with significant adipose tissue loss. The purpose of the study and it's four subprojects is to examine the safety and efficacy of various novel interventions designed to improve or resolve the fatty liver, hypertriglyceridemia, and insulin resistance or diabetes that is seen in these patients.
Conditions Studied
Interventions
- OTHER Diet
- OTHER low-fat diet ( Still recruiting )
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-04 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT00457938 record still lists
NCT00457938 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Diet is the first listed.
NCT00457938 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00457938 about?
NCT00457938 is a clinical study titled "Novel Therapies for Metabolic Complications of Lipodystrophies". Lipodystrophies represent a therapeutic challenge with regards to the management of the diabetes, insulin resistance, hypertriglyceridemia and fatty liver which frequently present in conjunction with significant adipose tissue loss. The purpose of the study and it's four subprojects is to examine th...
What is the current status of trial NCT00457938?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2006-04. Estimated completion is 2014-11.
What conditions does trial NCT00457938 study?
This clinical trial studies the following conditions: Diabetes, Insulin Resistance, Hypertriglyceridemia, Hepatic Steatosis.
What interventions are being tested in trial NCT00457938?
The interventions under investigation include: Diet (OTHER), low-fat diet ( Still recruiting ) (OTHER).
Who is sponsoring clinical trial NCT00457938?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00457938 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00457938's enrollment target sits among peer trials
4 337th of 338 higher than 2 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia